Neumora Therapeutics Investors Reminded of Filing Deadline in Class Action Lawsuit

NMRA Deadline in 5 Days: Kessler Topaz Meltzer Check LLP Reminds Neumora Therapeutics Inc. (NMRA) Investors of Upcoming Deadline

PITTSBURGH, April 25, 2023 /PRNewswire/ -- Kessler Topaz Meltzer Check, LLP reminds Neumora Therapeutics Inc. (NMRA) investors that a deadline to seek a lead plaintiff in a securities class action lawsuit is quickly approaching. The deadline is May 1, 2023, and investors who purchased or acquired NMRA securities between March 14, 2023, and April 13, 2023, are encouraged to contact Kessler Topaz Meltzer Check, LLP to learn more about the lawsuit and the potential benefits of participating in the case.

The lawsuit alleges that Neumora Therapeutics Inc. and certain of its officers and directors made false and misleading statements to the public and investors, causing a decline in the value of NMRA's securities. The lawsuit seeks to recover damages for NMRA investors who purchased or acquired NMRA securities during the class period.

Investors who purchased or acquired NMRA securities between March 14, 2023, and April 13, 2023, are encouraged to contact Kessler Topaz Meltzer Check, LLP to learn more about the lawsuit and the potential benefits of participating in the case. Investors who wish to serve as the lead plaintiff in the lawsuit must submit their application by May 1, 2023.

About Kessler Topaz Meltzer Check, LLP

Kessler Topaz Meltzer Check, LLP is a boutique law firm that specializes in securities class action litigation. The firm has a proven track record of recovering millions of dollars for investors who have been harmed by corporate wrongdoing. For more information, please visit our website at https://www.ktmc.com.

Contact: Kessler Topaz Meltzer Check, LLP Pittsburgh, PA 15219 Phone: (888) 299-7706 Email: info@ktmc.com Website: https://www.ktmc.com